bluebird bio Inc (BLUE)
0.3799
-0.01
(-2.79%)
USD |
NASDAQ |
Nov 13, 16:00
0.40
+0.02
(+5.29%)
After-Hours: 20:00
bluebird bio Revenue (TTM): 54.90M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 54.90M |
March 31, 2024 | 45.69M |
December 31, 2023 | 29.50M |
September 30, 2023 | 21.73M |
June 30, 2023 | 9.405M |
March 31, 2023 | 4.034M |
December 31, 2022 | 3.598M |
September 30, 2022 | 5.141M |
June 30, 2022 | 6.089M |
March 31, 2022 | 4.713M |
December 31, 2021 | 3.662M |
September 30, 2021 | -237.97M |
June 30, 2021 | -219.72M |
March 31, 2021 | -20.97M |
December 31, 2020 | 0.00 |
September 30, 2020 | 205.35M |
June 30, 2020 | 194.99M |
March 31, 2020 | 9.392M |
December 31, 2019 | 0.00 |
September 30, 2019 | 53.92M |
June 30, 2019 | 56.54M |
March 31, 2019 | 51.09M |
December 31, 2018 | 54.58M |
September 30, 2018 | 39.50M |
Date | Value |
---|---|
June 30, 2018 | 35.69M |
March 31, 2018 | 44.55M |
December 31, 2017 | 35.43M |
September 30, 2017 | 32.81M |
June 30, 2017 | 26.65M |
March 31, 2017 | 11.49M |
December 31, 2016 | 6.155M |
September 30, 2016 | 6.075M |
June 30, 2016 | 5.847M |
March 31, 2016 | 9.235M |
December 31, 2015 | 14.08M |
September 30, 2015 | 18.99M |
June 30, 2015 | 24.04M |
March 31, 2015 | 25.43M |
December 31, 2014 | 25.42M |
September 30, 2014 | 25.37M |
June 30, 2014 | 25.39M |
March 31, 2014 | 25.39M |
December 31, 2013 | 20.18M |
September 30, 2013 | 13.93M |
June 30, 2013 | 7.631M |
March 31, 2013 | 1.382M |
December 31, 2012 | 0.34M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
-237.97M
Minimum
Sep 2021
205.35M
Maximum
Sep 2020
6.291M
Average
5.141M
Median
Sep 2022
Revenue (TTM) Benchmarks
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 38.05M |
Predictive Oncology Inc | 1.748M |
Spectral AI Inc | 22.53M |
AIM ImmunoTech Inc | 0.201M |